Inventor · disambiguated record
Philippe Jm Dor
Also filed as: DOR PHILIPPE J M · DOR PHILIPPE JM
7 granted patents·7 pending applications·197 citations·filing 2004–2017
88Inventor score
Files withSANTEN PHARMACEUTICAL CO LTD9COOPER EUGENE R1DOR PHILIPPE J M1MACUSIGHT INC1MUDUMBA SREENIVASU1
Top patents by PatentIndex Score
14 records- 0195US8367097B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2010·Granted Feb 5, 2013·31 cites·14 claims
- 0295US7585517B2Transscleral deliveryMACUSIGHT INC·Filed 2004·Granted Sep 8, 2009·101 cites·31 claims
- 0394US8927005B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Jan 6, 2015·20 cites·20 claims
- 0490US8663639B2Formulations for treating ocular diseases and conditionsDOR PHILIPPE J M·Filed 2008·Granted Mar 4, 2014·37 cites·11 claims
- 0583US9387165B2Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 12, 2016·3 cites·7 claims
- 0682US8637070B2Rapamycin formulations and methods of their useMUDUMBA SREENIVASU·Filed 2006·Granted Jan 28, 2014·4 cites·8 claims
- 0776US9381153B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 5, 2016·1 cites·2 claims
- 0865US2018311152A1Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 0964US2017266109A1Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 1062US2016303093A1Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 1161US2017020809A1Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 1258US2012034279A1Transscleral deliveryCOOPER EUGENE R·Filed 2011·Application pending·0 cites
- 1354US2017049786A1Mtor pathway inhibitors for treating ocular disordersSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 1450US2012114637A1Mtor pathway inhibitors for treating ocular disordersNIVAGGIOLI THIERRY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philippe Jm Dor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →